• Home
  • Company
  • Our Lead Product
  • Pipeline
  • News-Media
  • Contact Us
  • Home
  • Company
  • Our Lead Product
  • Pipeline
  • News-Media
  • Contact Us

Company

Startseite » Company
Augxano and BIT Pharma enter into an Agreement for Commercialization Support in Asia 14. December 2022
Company
Augxano and BIT Pharma enter into an Agreement for Commercialization Support in Asia
ASPEN And BIT PHARMA Enter Into An Exclusive Agreement For A Nicardipine-Based Intracerebral Implant 29. October 2022
Company
ASPEN And BIT PHARMA Enter Into An Exclusive Agreement For A Nicardipine-Based Intracerebral Implant
PRESS INFORMATION 14. April 2021
Company
PRESS INFORMATION
BIT PHARMA TOP15 MOST PROMISING BIOTECH STARTUPS IN EUROPE 22. May 2020
Company
BIT PHARMA TOP15 MOST PROMISING BIOTECH STARTUPS IN EUROPE
BIT PHARMA ANNOUNCES CHANGE IN MANAGEMENT 10. December 2019
Company
BIT PHARMA ANNOUNCES CHANGE IN MANAGEMENT
LEAD PRODUCT
NicaPlant®
BIT PHARMA
Company
Lead Product
Pipeline
Team and Management
Scientific Literature
News-Media
Contact
LEGAL
Privacy Policy
Copyright

Funded by seed financing of the BMWFW, processed by Austria Wirtschafts Service.


BMWFW

Austria Wirtschaftsservice
© 2016 BIT Pharma. All Rights Reserved.
Contact Us

Send us an email for further inquiry.

Not readable? Change text.